When the market comes to understand the benefits being demonstrated by the entourage effect our CBDA, CBG, CBC, CBN, CBGA proprietary strain with almost no THC are having on peoples lives, namely parents and recipients of our recent ASD trials, let alone the other anti inflammatory characteristics of this strain, I expect a significant re rate.
Time and results will bring the recognition to us.
We are just cheap.
We are not a CBD company
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 6584 | 3 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable